Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Gains from Investment Securities (2021 - 2025)

Tivic Health Systems (TIVC) has 5 years of Gains from Investment Securities data on record, last reported at $4000.0 in Q2 2025.

  • For Q2 2025, Gains from Investment Securities changed N/A year-over-year to $4000.0; the TTM value through Jun 2025 reached $4000.0, changed N/A, while the annual FY2024 figure was $8868.0, 2515.93% up from the prior year.
  • Gains from Investment Securities reached $4000.0 in Q2 2025 per TIVC's latest filing, down from $35296.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $696630.0 in Q2 2022 and bottomed at $188.0 in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $178502.8, with a median of $35296.0 recorded in 2025.
  • Peak YoY movement for Gains from Investment Securities: tumbled 99.83% in 2022, then surged 2515.93% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $112500.0 in 2021, then crashed by 99.83% to $188.0 in 2022, then skyrocketed by 80.32% to $339.0 in 2023, then soared by 2515.93% to $8868.0 in 2024, then tumbled by 54.89% to $4000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $4000.0 in Q2 2025, $35296.0 in Q1 2025, and $8868.0 in Q4 2024.